Bitterman Chris T. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Bitterman Chris T.
Vice Pres Sales & Marketing
Transactions
- Award
Options (right to buy)
2025-03-17$5.17/sh+2,750$14,218→ 16,000 totalExercise: $5.17From: 2029-03-17Exp: 2035-03-17→ Common Stock (2,750 underlying)